Skip to Content

WHO: Strawberry-Flavored HIV Medication Coming for Infants

TUESDAY, Dec. 1, 2020 -- A strawberry-flavored version of the first-line HIV medication dolutegravir will soon be available for infants.

The medication will come in a tablet that dissolves in water or juice, according to an announcement associated with World AIDS Day on Dec. 1, The New York Times reported. Each year, about 160,000 children worldwide -- mostly in Africa -- are newly infected with HIV, according to the World Health Organization.

"This is truly an advance," Elaine J. Abrams, M.D., chief of pediatrics for ICAP, the global health outreach arm of the Columbia University Mailman School of Public Health in New York City and leader of a WHO treatment guidelines panel, told The Times. "The products currently available for pediatric treatment are less than optimal. There have been a few new formulations, but they haven't been as successful as anticipated."

In another announcement, the WHO has approved the dapivirine ring, a vaginal insert that has shown to be effective in protecting against HIV in women who use it consistently, The Times reported.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Adherence to Low-Dose Aspirin Improves Pregnancy Outcomes

TUESDAY, Jan. 26, 2021 -- Adherence to a low-dose aspirin (LDA) regimen improves pregnancy outcomes for women with previous pregnancy loss, according to a study published online...

Revised WIC Food Package May Aid Child Development

MONDAY, Jan. 25, 2021 -- Revisions to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) may offer downstream child health benefits, such as...

FDA Approves First Monthly Injectable Regimen for HIV

FRIDAY, Jan. 22, 2021 -- The U.S. Food and Drug Administration approved the first monthly injectable, complete regimen for HIV-infected adults, the agency announced...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.